The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Cancer Policy

ASCO report shows decrease in the number of oncologists relative to aging population

Trump backs off the 100% pharma tariffs ultimatum

CDC updates childhood vaccine recommendations

NIH announces restrictions on human biospecimen sharing with China and other foreign adversaries

California enacts regulations on private equity acquisitions of healthcare facilities

United for Medical Research report shows NIH funding benefits patients, researchers

Clinical Roundup

Datroway improves OS as first-line therapy in metastatic TNBC, phase III trial shows

Five-treatment radiation regimen poised to become standard of care, phase III data show

OSUCCC–James researchers are using AI to better predict, diagnose lobular cancer

DNA sequencing tool reveals hidden mutations that can drive cancer

Next-gen CAR T cells show promise at treating solid tumors, USC study shows

McKesson oncologist survey report details the state of cell and gene therapy adoption and barriers

In The Clinic
Trials & Tribulations

Earlier diagnosis, better outcomes: Telemedicine has found a home in oncology

Conversation with The Cancer Letter
Trials & Tribulations

The Cancer Letter is an independent weekly news publication and the leading source for information on the issues that shape oncology.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account